India’s IP landscape is evolving at the intersection of innovation, brand protection, digital enforcement and public interest. This edition explores significant developments in patent law and public health, emerging biotechnology patent guidelines, patent examination trends, key trademark rulings, copyright damages and online piracy. Together, these developments offer valuable insights for businesses, innovators, brand owners and IP practitioners navigating an increasingly dynamic legal environment.
Patented Cancer Drugs: Can Public Health Override Patent Exclusivity?
When life-saving medicines become unaffordable, where does patent exclusivity stand? In a significant ruling, the Kerala High Court interpreted Section 100 of the Patents Act broadly enough to permit government manufacture and non-commercial supply of patented medicines to needy patients. However, it stopped short of directing the Government to exercise that power, leaving the decision to executive policy and further assessment of affordability and access. The judgment brings the balance between patent protection, public health and access to life-saving treatment into sharp focus.
India’s Draft Biotechnology Patent Guidelines 2026: What Innovators Need to Know
From gene editing to advanced biologics, biotechnology is testing the boundaries of patentability. India’s draft 2026 biotechnology patent guidelines address emerging technologies and examination issues relevant to pharma and biotech innovators. The proposals make this a timely moment for businesses to review patent claim drafting, technical disclosures and portfolio strategy. As the guidelines remain in draft form, their final shape and implementation will be important to watch.
Patent Refusals Must Be Reasoned, Not Merely Announced
A patent refusal needs more than a conclusion—it needs a clear explanation. The Madras High Court set aside a patent refusal after finding the reasoning on inventive step inadequate and remanded the matter for fresh consideration. The decision highlights the importance of reasoned examination, robust technical submissions and clear explanations of the inventive contribution claimed. For applicants, it reinforces the value of presenting evidence-backed technical advantages during prosecution.
Patent Processing in India: Backlog, Bottlenecks & the Fast Lane
Could the right filing route save years? India’s latest patent office data points to a record clearance year followed by renewed pressure at the first-examination stage. Yet eligible applicants using expedited examination can achieve grant or final disposal in an average of about a year in most cases, compared with several years through the normal route. Understanding eligibility and selecting the appropriate examination route can therefore be a strategic advantage for innovators.
Beer vs. Whisky: Delhi HC Restrains “Godfather” Whisky
Can two different alcoholic beverages still clash over the same brand? The Delhi High Court restrained Cartel Bros from manufacturing, marketing or selling whisky under “GODFATHER” or “GODFATHER’S”, finding a prima facie case in favour of Devans Modern Breweries. The decision underscores that goods need not be identical to qualify as allied and cognate products for trademark infringement and passing-off analysis. For brand owners, expansion into adjacent product categories demands careful clearance of existing marks.
Coined, Not Derived: The Limits of the Molecule-Based Defence
Can a pharmaceutical brand escape a trademark dispute because its name refers to an active ingredient? In Dr. Reddy’s Laboratories v. Razenta Pharmaceuticals, the Delhi High Court ordered cancellation of “DAPLOGIN”, finding it deceptively similar to the earlier mark “DAPLO”. The decision illustrates the limits of relying on a molecule-derived naming rationale or the presence of similar marks on the register. In the pharmaceutical sector, brand differentiation is an essential element of trademark risk management.
Film Copyright: ₹1.66 Crore in Damages Without Exact Proof of Loss
Must copyright owners quantify every rupee lost to infringement? The Bombay High Court’s Mumbai Bench awarded approximately ₹1.66 crore in copyright damages despite the absence of exact proof of loss. The ruling highlights that uncertainty over the precise quantum of damages need not defeat a claim where infringement and the fact of loss are established and a reasonable assessment can be made. For the film and entertainment industries, it reinforces the importance of protecting rights and documenting commercial arrangements.
Digital Piracy: Chasing Streaming Sites That Keep Changing Masks
Take down one piracy site, and another may appear overnight. The Delhi High Court’s evolving approach to dynamic injunctions addresses the challenge of mirror, redirect and clone websites that facilitate continued copyright infringement. The development offers copyright owners a potentially more effective enforcement mechanism against constantly shifting online piracy networks, while raising important questions about implementation and judicial oversight.
Design Examination Reports Move to Email from 2 October 2026
A small procedural shift with potentially significant deadline consequences. India’s Designs Office has moved to email-based communication of First Examination Reports from 2 October 2026. Applicants and representatives should ensure that email addresses recorded in Form-1 are accurate, active and regularly monitored. Strong docketing practices and prompt internal communication will be essential to avoid missing important examination correspondence.